A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia
NCT06019338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-12-10
Summary
The aim of the study is to establish the validity of a patient reported diary in TN . The following objectives have been identified:
1. To generate evidence to support diary content validity by performing qualitative research studies with TN patients and Healthcare Professionals (HCPs).
2. To provide further support to the diary, sensitivity to change, known groups validity (ability to differentiate between severity groups), and construct validity.
Conditions
- Trigeminal Neuralgia
Interventions
- OTHER
-
Pain Diary use
Validation of a pain diary specifically designed to capture pain dimensions of Trigeminal Neuralgia
Sponsors & Collaborators
-
Noema Pharma AG
lead INDUSTRY
Principal Investigators
-
Clinical Director · Noema Pharma AG
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-20
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
Classical Trigeminal Neuralgia and Sodium Channel Mutations
NCT03656497 ·Status: COMPLETED
-
Sphenopalatine Ganglion Blockade in Migraine
NCT05210192 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine
NCT06653218 ·Status: COMPLETED
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
Treatment of Atypical Resistant Facial Pain
NCT07250984 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
NCT04054024 ·Status: UNKNOWN ·Phase: PHASE2
-
Non-pharmacological Treatments in Migraine.
NCT05596058 ·Status: TERMINATED ·Phase: NA
-
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
NCT01381497 ·Status: COMPLETED
-
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
NCT00913107 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992 ·Status: COMPLETED
-
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
NCT01381523 ·Status: COMPLETED
-
Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study
NCT06868953 ·Status: NOT_YET_RECRUITING
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
NCT00257985 ·Status: COMPLETED ·Phase: NA
-
Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
NCT02101892 ·Status: COMPLETED ·Phase: NA
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine
NCT01653340 ·Status: COMPLETED ·Phase: NA
-
Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
NCT03772860 ·Status: UNKNOWN
-
Use Of SB-705498 In The Acute Treatment Of Migraine
NCT00269022 ·Status: COMPLETED ·Phase: PHASE2
-
My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring
NCT04828941 ·Status: UNKNOWN ·Phase: NA
-
Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine
NCT05516251 ·Status: UNKNOWN ·Phase: NA
-
Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)
NCT06267664 ·Status: RECRUITING
-
Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine
NCT06882122 ·Status: RECRUITING
-
Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments
NCT06562413 ·Status: RECRUITING
-
MLD10 in the Prevention of Migraine in Adults
NCT02322333 ·Status: COMPLETED ·Phase: PHASE2/PHASE3